+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sunitinib Malate - Global Market Trajectory & Analytics

  • ID: 5309820
  • Report
  • April 2021
  • Region: Global
  • 106 pages
  • Global Industry Analysts, Inc
Global Sunitinib Malate Market to Reach $160.8 Million by 2027

Amid the COVID-19 crisis, the global market for Sunitinib Malate estimated at US$66.8 Million in the year 2020, is projected to reach a revised size of US$160.8 Million by 2027, growing at a CAGR of 13.4% over the period 2020-2027.



The U.S. Market is Estimated at $19.7 Million, While China is Forecast to Grow at 12.9% CAGR

The Sunitinib Malate market in the U.S. is estimated at US$19.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.1 Million by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Select Competitors (Total 44 Featured):
  • Active Biotech AB
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Dendreon Corporation
  • Endo Pharmaceuticals, Inc.
  • Ferring Pharmaceuticals, Inc.
  • Ipsen Pharma
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TOLMAR Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Sunitinib Malate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Sunitinib Malate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Sunitinib Malate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 4: USA Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 5: USA Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • CANADA
  • Table 6: Canada Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 7: Canada Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • JAPAN
  • Table 8: Japan Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 9: Japan Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • CHINA
  • Table 10: China Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 11: China Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • EUROPE
  • Table 12: Europe Current & Future Analysis for Sunitinib Malate by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 13: Europe Historic Review for Sunitinib Malate by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 14: Europe 15-Year Perspective for Sunitinib Malate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • FRANCE
  • Table 15: France Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 16: France Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • GERMANY
  • Table 17: Germany Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 18: Germany Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • ITALY
  • Table 19: Italy Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 20: Italy Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • UNITED KINGDOM
  • Table 21: UK Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 22: UK Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • REST OF EUROPE
  • Table 23: Rest of Europe Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 24: Rest of Europe Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • ASIA-PACIFIC
  • Table 25: Asia-Pacific Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 26: Asia-Pacific Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • REST OF WORLD
  • Table 27: Rest of World Current & Future Analysis for Sunitinib Malate by Segment - Sunitinib Malate - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 28: Rest of World Historic Review for Sunitinib Malate by Segment - Sunitinib Malate Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown
Adroll
adroll